Malta: New Drug Scheme Offers Hope to Heart Failure Patients
Heart failure patients in Malta are set to benefit from a new drug scheme adding Sacubitril/valsartan to the POYC list, improving access to life-changing t
Heart failure patients in Malta are set to benefit from a new drug scheme adding Sacubitril/valsartan to the POYC list, improving access to life-changing t
The Ministry of Health in Malta adds Sacubitril/Valsartan to the POYC scheme, making life-saving heart failure treatment more accessible to Maltese patient